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Introduction
Aortic atherosclerotic plaque is associated with increased
risk of future cardiovascular events. Magnetic resonance
imaging (MRI) is a precise non-invasive tool for accurate
measurements of aortic wall thickness in patients with
advanced atherosclerosis and allows for monitoring
plaque regression.
Purpose
The purpose of this study was to assess the relationship
between changes in aortic wall thickness measured by
MRI in response to lipid modifying therapy.
Methods
114 participants age >65 years were enrolled in a double
blinded randomized trial as part of the NIA Plaque study.
Participants were randomly assigned to two treatment
groups; one receiving simvastatin and niacin and other
receiving simvastatin and placebo. Baseline MRI was per-
formed on all participants using a 1.5-Tesla scanner. Fol-
low-up MRI exams were done every 6 months for 18
months. Axial images of 3 segments of the thoracic aorta
(ascending, arch and descending) were obtained using a
double inversion recovery black blood fast spin-echo
sequence with ECG-gating. 0.1 mmol/kg of gadodiamide
contrast was given intravenously. Post contrast T1-
weighted images were used to evaluate the changes in ves-
sel wall thickness and lumen diameter over the course of
lipid therapy. Paired t test and multivariable regression
were used for data analyses.
Results
The mean age of the participants was 71 years and 83%
were men. Participants receiving simvastatin and niacin
had higher HDL (62 vs. 53 mg/dl, p = 0.0018), lower LDL
(70 vs. 78 mg/dl, p = 0.04) and triglycerides (90 vs. 111
mg/dl, p = 0.009) as compared to those receiving simvas-
tatin and placebo at the end of the 18 months. Wall thick-
ness was decreased by 6.6% (p = 0.02) and 8.2% (p =
0.01) at 12 and 18 months follow up respectively in the
ascending aorta and 10.2% (p = 0.003) at 18 months fol-
low up in the aortic arch. Plaque regression was directly
proportional to the increase in HDL cholesterol (p = 0.02)
and decrease in the LDL cholesterol Figure 1.
(p = 0.01). However, no difference in the plaque regres-
sion was noticed between the two treatment groups in the
study.
Conclusion
Our study demonstrates that thoracic aorta plaque regres-
sion can be detected accurately by MRI after 12 months of
lipid lowering therapy and was associated with the
increase in HDL and decrease in LDL levels. The addition
of Niacin to simvastatin compared to simvastatin alone
did not show any added benefit to the thoracic aorta
plaque regression.
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Serial T1-weighted post-gadolinium axial images of the descending thoracic aorta from the same patient showing the thoracic ao ta wall th ckness regressi n (Arrow)Figure 1
Serial T1-weighted post-gadolinium axial images of the descending thoracic aorta from the same patient 
showing the thoracic aorta wall thickness regression (Arrow).Page 2 of 2
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